Drug discovery and development company focused on infectious diseases and the treatment of drug-resistant bacteria
Location: United States, North Carolina, Chapel Hill
Total raised: $15M
Investors 2
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | Hercules C... | htgc.com |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 09.09.2014 | - | $10M | - | aislingcap... |
| 17.08.2011 | - | $5M | - | medcitynew... |
Mentions in press and media 22
| Date | Title | Description | Category | Author | Source |
| 09.09.2014 | Cempra, In... | Toyama Receives Regulatory Cle... | - | - | aislingcap... |
| 09.09.2014 | Cempra get... | Interestingly, antibiotic resi... | - | - | medcitynew... |
| 30.03.2012 | Antibiotic... | “Every day has value,” Fernand... | - | - | medcitynew... |
| 07.03.2012 | No IPO for... | But the public markets have re... | - | - | medcitynew... |
| 03.02.2012 | Cempra IPO... | Cempra has two clinical-stage ... | - | - | medcitynew... |
| 31.01.2012 | Cempra IPO... | Cempra’s two lead drug candida... | - | - | medcitynew... |
| 16.01.2012 | IPO for Ce... | Proceeds from the Cempra IPO w... | - | - | medcitynew... |
| 13.10.2011 | Cempra IPO... | While the antibiotic market is... | - | - | medcitynew... |
| 15.09.2011 | Cempra ant... | But levofloxacin carries safet... | - | - | medcitynew... |
| 17.08.2011 | Antibacter... | A Cempra spokesman said the co... | - | - | medcitynew... |
Show more